Endocrinology Test
|
|
| 1. Zona glomerulosa: |
|
|
| 2. In Europe, first-line treatment option in Graves’ disease is: |
|
|
| 3. Which of the following is the principal inhibitor of prolactin: |
|
|
| 4. The typical diagnostic trade for Men 2A syndrome is: |
|
|
| 5. The typical sequence of hormonal loss in hypopituitarism is: |
|
|
| 6. The clinical suggestive features for thyroid malignancy are: |
|
|
| 7. The peak bone mass is dependent on: |
|
|
| 8. In central diabetes insipidus : |
|
|
| 9. The etiology of pituitary insufficiency includes: |
|
|
| 10. In pituitary tumors with compression of the cavernous sinus: |
|
|
| 11. Contraindication of sexual steroid supplementation in males are: |
|
|
| 12. Testosterone has the following effects in men: |
|
|
| 13. SIADH syndrome appears in the following circumstances: |
|
|
| 14. Which of the following statements regarding corticotropin-releasing hormone are true: |
|
|
| 15. The parathyroid hormone acts in order to: |
|
|
| 16. Subclinical hyperparathyroidism has to be considered in the following situations: |
|
|
| 17. Differential diagnostic of gigantism has to be made with: |
|
|
| 18. Which of the following thyroid ultrasound signs are suspicious for malignancy in a nodule: |
|
|
| 19. The control mechanisms of arginine vasopressin release include: |
|
|
| 20. In cortisol –secreting adrenal adenoma: |
|
|
| 21. Which statements regarding pheocromocytoma are true: |
|
|
| 22. The following are true regarding primary adrenal insufficiency: |
|
|
| 23. In hypothyroidism we see: |
|
|
| 24. Patients with Cushing syndrome can present: |
|
|
| 25. In primary hyperparathyroidism laboratory tests show: |
|